Disciplined Investments’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-93
Closed -$20.6K 179
2023
Q2
$20.6K Sell
93
-1
-1% -$232 0.01% 280
2023
Q1
$22.7K Sell
94
-7
-7% -$1.72K 0.01% 301
2022
Q4
$26.5K Hold
101
0.01% 263
2022
Q3
$23K Sell
101
-7
-6% -$1.7K 0.01% 295
2022
Q2
$26K Buy
108
+12
+13% +$2.94K 0.01% 286
2022
Q1
$23K Buy
96
+46
+92% +$10.6K 0.01% 315
2021
Q4
$11K Hold
50
﹤0.01% 345
2021
Q3
$11K Buy
+50
New +$11.5K 0.01% 300
2020
Q3
Sell
-264
Closed -$62K 404
2020
Q2
$62K Hold
264
0.05% 147
2020
Q1
$54K Sell
264
-10
-4% -$2.18K 0.05% 145
2019
Q4
$66K Buy
+274
New +$60.4K 0.06% 145

Other funds holding AMGN

Disciplined Investments's AMGN Position: Q3 2023 in Review

Disciplined Investments sold out of Amgen (AMGN) in Q3 2023, closing a stake of 93 shares — an estimated $20.6K sold.

Disciplined Investments first reported a position in AMGN in Q4 2019 and held it in 11 quarters. The position peaked at $66K in Q4 2019. 2,501 funds tracked by Wall St. Rank hold AMGN as of Q3 2023.

  • Disciplined Investments reported no remaining Amgen position as of Q3 2023 after selling out during the quarter.
  • Disciplined Investments sold 93 Amgen shares in Q3 2023, an estimated $20.6K.
  • Disciplined Investments first reported a position in Amgen in Q4 2019 and held it in 11 quarters.
  • Disciplined Investments's Amgen position peaked at $66K in Q4 2019.
  • 2,501 funds tracked by Wall St. Rank held Amgen as of Q3 2023.

Based on Disciplined Investments's 13F filing for Q3 2023, filed 14 Nov 2023.